Multi-stakeholder platform with experts in clinical development for Leber congenital amaurosis including recent clinical data for sepofarsen, an investigational therapy for LCA10.
Since 1964, support has been shown for the blind and visually impaired community by creating the awareness day, White Cane Awareness Day. Read more about what the colors of a cane mean and about the history of this awareness day.
We are pleased to welcome Naveed Shams, MD, PhD to our management team as Chief Scientific Officer. He will be leading research as well as the early clinical development of ProQR's investigational RNA therapies for inherited retinal diseases.
The ProQR family is growing fast and we spoke to the Chief Medical Officer Aniz Girach who joined ProQR in 2019. We asked him about his impression of the company after he joined, as well as the new developments he’s been working on.
He is one of the founders of ProQR, but even long before that Gerard Platenburg was involved in the development of RNA therapies. Even so, after decades of working on them he still gets enthusiastic when talking about RNA.
There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan joined in 2013, she was only employee number six. As a result, she has seen the company grow and develop.
